This week, HB 2444, test and treat legislation, passed out of the House of Representatives, passing 33–22, with 4 not voting and 1 vacant seat. This bill would permit pharmacists, pursuant to a statewide written protocol, to independently order, perform and interpret CLIA-waived tests and initiate treatment to individuals 12 years of age or the age authorized by the treatment, whichever is older, including influenza, group A streptococcus pharyngitis, COVID, or a condition related to an emerging or existing public health threat. PEP and PrEP remained in the bill, with certain additional requirements.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.